0001209191-16-137392.txt : 20160816 0001209191-16-137392.hdr.sgml : 20160816 20160816202324 ACCESSION NUMBER: 0001209191-16-137392 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160816 FILED AS OF DATE: 20160816 DATE AS OF CHANGE: 20160816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STANLEY THEODORE H CENTRAL INDEX KEY: 0000938296 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 161837331 MAIL ADDRESS: STREET 1: 4745 WILEY POST WAY SUITE 650 STREET 2: C/O ANESTA CORP CITY: SALT LAKE CITY STATE: UT ZIP: 84116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-16 0 0001516479 Insys Therapeutics, Inc. INSY 0000938296 STANLEY THEODORE H C/O INSYS THERAPEUTICS, INC. 444 SOUTH ELLIS STREET CHANDLER AZ 85224 1 0 0 0 Common Stock 2016-08-16 4 M 0 15000 5.96 A 17000 D Common Stock 2016-08-16 4 S 0 15000 18.02 D 2000 D Common Stock 6000 I by non-profit corporation Common Stock 10200 I by limited partnership Stock Option (right to buy) 5.96 2016-08-16 4 M 0 15000 0.00 D 2023-08-12 Common Stock 15000 15000 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.95 to $18.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein. The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015. One third of the shares subject to the option vested on August 12, 2014 and the remainder vested in 24 equal monthly installments thereafter until fully vested and exercisable on August 12, 2016. On March 27, 2014 and June 5, 2015 the Issuer effected a 3-for-2 forward stock split and a 2-for-1 forward stock split, respectively, both pursuant to a stock dividend, resulting in the reporting person's ownership of an aggregate of 15,000 additional options. /s/ Darryl S. Baker, Attorney-in-fact 2016-08-16